Long acting injection versus oral risperidone in first-episode schizophrenia: differential impact on white matter myelination trajectory (Q35211261)

7 August 2017

title

Long acting injection versus oral risperidone in first-episode schizophrenia: differential impact on white matter myelination trajectory (English)

1 reference

7 August 2017

0 references

1 reference

1 reference

Keith H. Nuechterlein

12

object named as

Keith H Nuechterlein

1 reference

7 August 2017

6

Lori L Altshuler

1 reference

7 August 2017

George Bartzokis

1

1 reference

7 August 2017

Po H Lu

2

1 reference

7 August 2017

Chetan P Amar

3

1 reference

7 August 2017

Erika P Raven

4

1 reference

7 August 2017

Nicole R Detore

5

1 reference

7 August 2017

Jim Mintz

7

1 reference

7 August 2017

Joseph Ventura

8

1 reference

7 August 2017

Laurie R Casaus

9

1 reference

7 August 2017

John S Luo

10

1 reference

7 August 2017

Kenneth L Subotnik

11

1 reference

7 August 2017

language of work or name

English

0 references

publication date

20 July 2011

1 reference

7 August 2017

number of pages

7

1 reference

inferred from page(s)

published in

Schizophrenia Research

1 reference

7 August 2017

volume

132

1 reference

7 August 2017

issue

1

1 reference

7 August 2017

page(s)

35-41

1 reference

Dopamine D2 receptors as treatment targets in schizophrenia

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Outcome of first-episode schizophrenia in India: longitudinal study of effect of insight and psychopathology

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

The impact on schizophrenia-related hospital utilization and costs of switching to long-acting risperidone injections in Sweden

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Volumetric white matter abnormalities in first-episode schizophrenia: a longitudinal, tensor-based morphometry study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Longitudinal study of brain morphology in first episode schizophrenia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Lipid composition of the normal human brain: gray matter, white matter, and myelin

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

MR imaging of the various stages of normal myelination during the first year of life

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Cholesterol of myelin is the determinant of gray-white contrast in MRI of brain

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Formation, maturation, and disorders of white matter

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Developmental Processes in Schizophrenic Disorders: longitudinal studies of vulnerability and stress

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Neuroglialpharmacology: white matter pathophysiologies and psychiatric treatments

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Haloperidol activates quiescent oligodendroglia precursor cells in the adult mouse brain

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Behavioral and neurobiological changes in C57BL/6 mouse exposed to cuprizone: effects of antipsychotics.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Grey and white matter abnormalities are associated with impaired spatial working memory ability in first-episode schizophrenia

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST).

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Individual placement and support for individuals with recent-onset schizophrenia: integrating supported education and supported employment.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlates.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Classifying episodes in schizophrenia and bipolar disorder: criteria for relapse and remission applied to recent-onset samples.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Reduced intracortical myelination in schizophrenia

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

High cholesterol level is essential for myelin membrane growth

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Reliability of in vivo volume measures of hippocampus and other brain structures using MRI.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Time course and biologic correlates of treatment response in first-episode schizophrenia

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Lipids in the nervous system of different species as a function of age: brain, spinal cord, peripheral nerve, purified whole cell preparations, and subcellular particulates: regulatory mechanisms and membrane structure.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3172389

Neurobiology and the natural history of schizophrenia

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21767934

12 December 2020

inferred from PubMed ID database lookup

Biological underpinnings of treatment resistance in schizophrenia: an hypothesis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21767934

12 December 2020

inferred from PubMed ID database lookup

Equivalent switching dose from oral risperidone to risperidone long-acting injection: a 48-week randomized, prospective, single-blind pharmacokinetic study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21767934

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1016/J.SCHRES.2011.06.029

1 reference

7 August 2017

1 reference

7 August 2017

1 reference